![](/img/cover-not-exists.png)
Is electromotive mitomycin C an alternative treatment for frail patients with high-risk non-muscle invasive bladder cancer who have failed intravesical BCG?
B.E. Ayres, B.S.I. Montgomery, T. Parker, J. Borwell, N.J. BarberVolume:
2
Year:
2009
Language:
english
DOI:
10.1016/j.bjmsu.2009.09.003
File:
PDF, 38 KB
english, 2009